AHR Form 144: Notice to sell 1500 shares; value 74030 on NYSE

American Healthcare REIT (AHR) received a Form 144 notice indicating a planned sale of 1500 common shares.

Accepted by SEC EDGAR 11/12/2025 - 03:44 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

American Healthcare REIT (AHR) received a Form 144 notice indicating a planned sale of 1500 common shares. The filing lists an aggregate market value of 74030, with an approximate sale date of 11/11/2025 on the NYSE, using broker Merrill (8890 Lyra Drive, Columbus, OH).

The shares to be sold were acquired via Restricted Stock Vesting on 03/25/2025 in the amount of 1500. Over the prior three months, a related sale shows 3850 common shares with gross proceeds of 161156 by Mark Foster. The table also lists 176908238 shares outstanding.

Form 144 is a notice of intent to sell restricted or control securities and is an administrative disclosure rather than a financing transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AHR's Form 144 filing disclose?

It discloses an intent to sell 1500 AHR common shares with an aggregate market value of 74030, targeting an approximate sale date of 11/11/2025 on the NYSE.

How were the AHR shares being sold acquired?

They were acquired via Restricted Stock Vesting on 03/25/2025 in the amount of 1500 shares.

Which broker is listed for the planned AHR share sale?

The filing lists Merrill, 8890 Lyra Drive, 5th Floor, Columbus, OH 43240.

What prior AHR share sales are noted in the last 3 months?

A sale of 3850 common shares on 09/03/2025 with gross proceeds of 161156 by Mark Foster.

What number of AHR shares outstanding is listed?

The table lists 176908238 shares outstanding.

On which exchange is the planned sale of AHR shares?

The planned sale is listed for the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001941750
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	American Healthcare REIT, Inc.
SEC File Number	001-41951
Address of Issuer	18191 Von Karman Avenue Suite 300 Irvine CALIFORNIA 92612
Phone	949-270-9200
Name of Person for Whose Account the Securities are To Be Sold	Mark Foster
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Drive, 5th Floor Columbus OH 43240	1500	74030	176908238	11/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/25/2025	Restricted Stock Vesting	American Healthcare REIT Inc			1500	03/25/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Foster 18191 Von Karman Avenue Suite 300 Irvine CA 92612	Common	09/03/2025	3850	161156

144: Remarks and Signature

Remarks
Date of Notice	11/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Mark Foster
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)